SIMPLMAB

Bio-pharmaceutical preparations containing monoclonal antibodies (MABs) for use in human and veterinary medicine, namely, for the treatment of cancers, infectious diseases and other chronic diseases, namely, Encephalitis, Hepatitis C, Tuberculosis, bladder cancer, travelers' diarrhea and Streptococci; vaccines; antibodies for use in human and veterinary medicine, namely, for the treatment of cancers, infectious diseases and other chronic diseases, namely, Encephalitis, Hepatitis C, Tuberculosis, bladder cancer, travelers' diarrhea and Streptococci; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; chemical preparations used in medical science, namely, for diagnosis, treatment and monitoring of cancer, infectious diseases and other chronic diseases, namely, Encephalitis, Hepatitis C, Tuberculosis, bladder cancer, travelers' diarrhea and Streptococci, all of the foregoing containing monoclonal antibodies

Development of medical test methods; chemical, medical, pharmaceutical and bacteriological research; laboratory services relating to the production of antibodies